Sandra L. Friedman, M.D., M.P.H., M.S.. B.S. Speech Pathology University of Illinois. M.S. Speech Pathology, University of Michigan. M.D. Northwestern University School of Medicine. M.P.H. Harvard School of Public Health.
Dr. Friedman joined the University of Colorado School of Medicine and The Children's Hospital, Denver in September 2009 as Section Head of Neurodevelopmental and Behavioral Pediatrics. She also serves as program director of Developmental and Behavioral Pediatrics fellowship program, accredited by ACGME in 2010. Prior to coming to Denver, she had been a staff physician at The Children's Hospital Boston (CHB) and faculty at Harvard Medical School (HMS) for 16 years. She is a developmental pediatrician who has been involved in developmental assessments and management of children with a wide range of developmental problems and special health care needs. She functioned as program director for the Neurodevelopmental Disabilities residency program at CHB and HMS. She also was Director of Pediatric Training for the Leadership Education in Neurodevelopmental Disabilities program at CHB and the Institute for Community Inclusion. She has presented at multiple local and national conferences, and provided technical assistance to national and international organizations. She has published journal articles, abstracts, book chapters, and co-edited a book on end-of-life care as it pertains to people with IDD. Her research has also focused on developmental and medical outcomes of children born with congenital diaphragmatic hernia, autism spectrum disorders, and children with special health care needs. She has served on the board of directors of the American Association on Intellectual and Developmental Disabilities and on the executive council of the Committee on Children with Disabilities of the American Academy of Pediatrics. Her major areas of scientific interest are children with special health care needs, end-of-life care, and autism spectrum disorders.
